Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India.
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Raebareli, UP, India.
Curr Neuropharmacol. 2021;19(11):1984-2011. doi: 10.2174/1570159X19666210215123914.
According to the World Health Organization, Traumatic brain injury (TBI) is the major cause of death and disability and will surpass the other diseases by the year 2020. Patients who suffer TBI face many difficulties which negatively affect their social and personal life. TBI patients suffer from changes in mood, impulsivity, poor social judgment and memory deficits. Both open and closed head injuries have their own consequences. Open head injury associated problems are specific in nature e.g. loss of motor functions whereas closed head injuries are diffused in nature like poor memory, problems in concentration etc. Brain injury may have a detrimental effect on the biochemical processes responsible for the homeostatic and physiological disturbances in the brain. Although significant research has been done in order to decrease the overall TBI-related mortality, many individuals suffer from a life-long disability. In this article, we have discussed the causes of TBI, its consequence and the pathobiology of secondary injury. We have also tried to discuss the evidence-based strategies which are shown to decline the devastating consequences of TBI.
根据世界卫生组织的统计,创伤性脑损伤(TBI)是死亡和残疾的主要原因,到 2020 年它将超过其他疾病。TBI 患者面临许多困难,这些困难对他们的社会和个人生活产生负面影响。TBI 患者的情绪、冲动、社交判断力差和记忆力减退等方面都受到影响。开放性和闭合性颅脑损伤都有其自身的后果。开放性颅脑损伤相关的问题具有特定的性质,例如运动功能丧失,而闭合性颅脑损伤则是弥散性的,如记忆力差、注意力集中问题等。脑损伤可能对负责大脑内稳态和生理紊乱的生化过程产生有害影响。尽管已经进行了大量研究以降低总体 TBI 相关死亡率,但仍有许多人患有终身残疾。在本文中,我们讨论了 TBI 的原因、后果和继发性损伤的病理生物学。我们还试图讨论已显示出可降低 TBI 破坏性后果的基于证据的策略。